BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
US Department of Justice
Queensland Health
Daiichi Sankyo

Generated: December 15, 2017

DrugPatentWatch Database Preview

Serotonin and Norepinephrine Reuptake Inhibitor Drug-Class List

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms UsaVENLAFAXINE HYDROCHLORIDEvenlafaxine hydrochlorideTABLET;ORAL077653-003Jun 13, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Alembic Pharms LtdVENLAFAXINE HYDROCHLORIDEvenlafaxine hydrochlorideTABLET;ORAL078932-001Dec 14, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
TevaVENLAFAXINE HYDROCHLORIDEvenlafaxine hydrochlorideTABLET;ORAL076690-005Aug 3, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs LtdVENLAFAXINE HYDROCHLORIDEvenlafaxine hydrochlorideTABLET;ORAL078301-002Jun 13, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs LtdVENLAFAXINE HYDROCHLORIDEvenlafaxine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL078421-002May 6, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds IncVENLAFAXINE HYDROCHLORIDEvenlafaxine hydrochlorideTABLET;ORAL078627-004Jun 13, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
MylanVENLAFAXINE HYDROCHLORIDEvenlafaxine hydrochlorideTABLET;ORAL077166-004Jun 13, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Osmotica PharmVENLAFAXINE HYDROCHLORIDEvenlafaxine hydrochlorideTABLET, EXTENDED RELEASE;ORAL022104-001May 20, 2008ABRXYesNo► Subscribe► Subscribe► Subscribe
Heritage Pharms IncVENLAFAXINE HYDROCHLORIDEvenlafaxine hydrochlorideTABLET;ORAL078554-002Jan 9, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa IncVENLAFAXINE HYDROCHLORIDEvenlafaxine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL090174-001Apr 14, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Cantor Fitzgerald
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: